Dalila Sellami
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Dermatology top 5%
- Cancer and Skin Lesions
Papers in
-
- Cancer and Skin Lesions 8
- Oncology 18
- Cancer Treatment and Pharmacology 7
- HER2/EGFR in Cancer Research 5
- Co-authors
- Oezlem AnakLi‐Tzong ChenYoon‐Koo KangAndrew X. ZhuRonnie T.P. PoonEric AssénatKevin PerraudBruno Daniele
- Journals
- Journal of Clinical Oncology (10 papers)Annals of Oncology (5 papers)Cancer Research (3 papers)Molecular Cancer Therapeutics (2 papers)European Journal of Cancer (2 papers)
- Partner nations
- United StatesSwitzerlandFrance
In The Last Decade
Dalila Sellami
44 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 71
- Hepatology 421
- Dermatology 157
- Pathology and Forensic Medicine 298
- Oncology 411
- Cancer Research 222
Countries citing papers authored by Dalila Sellami
This map shows the geographic impact of Dalila Sellami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalila Sellami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalila Sellami more than expected).
Fields of papers citing papers by Dalila Sellami
This network shows the impact of papers produced by Dalila Sellami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalila Sellami. The network helps show where Dalila Sellami may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dalila Sellami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 13 | |
| 3 | 2018 | 34 | |
| 4 | 2017 | 137 | |
| 5 | 2017 | 8 | |
| 6 | 2017 | 15 | |
| 7 | Investigator-assessed efficacy and safety of sonidegib in patients with locally advanced basal cell carcinoma and metastatic basal cell carcinoma: results of the BOLT 30-month analysis | 2016 | 1 |
| 8 | 2016 | 2 | |
| 9 | 2016 | 7 | |
| 10 | 2016 | 33 | |
| 11 | 2015 | 60 | |
| 12 | 2014 | 2 | |
| 13 | 2014 | 11 | |
| 14 | 2013 | 18 | |
| 15 | 2013 | 57 | |
| 16 | 2012 | 1 | |
| 17 | 2004 | 37 | |
| 18 | [Mammography screening of breast cancer in Tunisia. Results of first experience]. | 2003 | 2 |
| 19 | 2000 | 11 | |
| 20 | Controlateral axillary nodal metastases of breast cancer | 1998 | 3 |
About Dalila Sellami
Dalila Sellami is a scholar working on Dermatology, Oncology, Pulmonary and Respiratory Medicine, Pharmacy and Pathology and Forensic Medicine, having authored 45 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hedgehog Signaling Pathway Studies (14 papers), Nonmelanoma Skin Cancer Studies (11 papers), Advanced Breast Cancer Therapies (9 papers), PI3K/AKT/mTOR signaling in cancer (9 papers), Cancer and Skin Lesions (8 papers), Cancer Treatment and Pharmacology (7 papers), HER2/EGFR in Cancer Research (5 papers) and Lung Cancer Treatments and Mutations (5 papers). The work is most often cited by research in Hepatology (421 citations), Dermatology (157 citations), Pathology and Forensic Medicine (298 citations), Oncology (411 citations) and Cancer Research (222 citations). Dalila Sellami has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Oezlem Anak, Li‐Tzong Chen, Yoon‐Koo Kang, Andrew X. Zhu, Ronnie T.P. Poon, Eric Assénat, Kevin Perraud, Bruno Daniele, Arndt Vogel and Markus Peck‐Radosavljevic. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Molecular Cancer Therapeutics and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.